P3 Health Partners PE Ratio 2020-2025 | PIII
Current and historical p/e ratio for P3 Health Partners (PIII) from 2020 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. P3 Health Partners PE ratio as of July 29, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| P3 Health Partners PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-07-29 | 5.80 | 0.00 | |
| 2025-03-31 | 8.21 | $-47.28 | 0.00 |
| 2024-12-31 | 11.25 | $-49.00 | 0.00 |
| 2024-09-30 | 19.32 | $-42.00 | 0.00 |
| 2024-06-30 | 22.52 | $-32.50 | 0.00 |
| 2024-03-31 | 51.50 | $-29.50 | 0.00 |
| 2023-12-31 | 70.50 | $-32.50 | 0.00 |
| 2023-09-30 | 73.50 | $-113,033.00 | 0.00 |
| 2023-06-30 | 149.50 | $-113,040.50 | 0.00 |
| 2023-03-31 | 53.00 | $-113,036.00 | 0.00 |
| 2022-12-31 | 92.00 | $-113,025.00 | 0.00 |
| 2022-09-30 | 231.00 | $-13.50 | 0.00 |
| 2022-06-30 | 186.00 | 0 | 0.00 |
| 2022-03-31 | 391.00 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.050B | $1.500B |
| P3 Health Partners is a patient-centered and physician-led population health management company. P3 Health Partners, formerly known as Foresight Acquisition Corp., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.813B | 60.83 |
| Hims & Hers Health (HIMS) | United States | $13.134B | 136.46 |
| Doximity (DOCS) | United States | $11.457B | 53.04 |
| Tempus AI (TEM) | United States | $10.733B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.377B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.856B | 60.24 |
| Hinge Health (HNGE) | United States | $3.535B | 0.00 |
| Privia Health (PRVA) | United States | $2.402B | 164.17 |
| 10x Genomics (TXG) | United States | $1.803B | 0.00 |
| Schrodinger (SDGR) | United States | $1.643B | 0.00 |
| Phreesia (PHR) | United States | $1.614B | 0.00 |
| Azenta (AZTA) | United States | $1.562B | 72.62 |
| Enovis (ENOV) | United States | $1.561B | 8.70 |
| Clover Health Investments (CLOV) | United States | $1.527B | 0.00 |
| Omnicell (OMCL) | United States | $1.358B | 23.97 |
| Evolent Health (EVH) | United States | $1.133B | 96.50 |
| Claritev (CTEV) | United States | $0.664B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.549B | 0.00 |
| Standard BioTools (LAB) | United States | $0.539B | 0.00 |
| Veradigm (MDRX) | United States | $0.507B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.480B | 0.00 |
| Talkspace (TALK) | United States | $0.428B | 128.00 |
| TruBridge (TBRG) | United States | $0.347B | 771.00 |
| Outset Medical (OM) | United States | $0.320B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.285B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.244B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.224B | 0.00 |
| CapsoVision (CV) | United States | $0.202B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.199B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.157B | 0.00 |
| American Well (AMWL) | United States | $0.136B | 0.00 |
| Pulmonx (LUNG) | United States | $0.124B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.123B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.120B | 0.00 |
| CareCloud (CCLD) | United States | $0.104B | 3.95 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.092B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.080B | 0.00 |
| 111 (YI) | China | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| PROFUSA (PFSA) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |